title: A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected].
abstract: von Willebrand factor interaction with glycoprotein Ib alpha (GPIb alpha) plays a critical role in the initial phase of platelet adhesion at high shear rates, and it may also play a role in platelet thrombus formation in partially occluded arteries. Previous studies have indicated that two peptides, Cys-474--Pro-488 (peptide 153) and Ser-692--Pro-708 (peptide 154), inhibit von Willebrand factor--GPIb alpha interaction. We have expressed a recombinant fragment of von Willebrand factor, Leu-504--Lys-728 [corrected], with a single intrachain disulfide bond linking residues Cys-509--Cys-695 and examined its ability to inhibit von Willebrand factor--GPIb alpha interactions and platelet adhesion at high shear forces. This recombinant fragment, named VCL, inhibits ristocetin-induced, botrocetin-induced, and asialo-von Willebrand factor-induced platelet aggregation and binding to platelets at an IC50 = 0.011-0.260 microM, significantly lower than the IC50 of peptide 153 or 154, IC50 = 86-700 microM. Peptides 153 and 154 did not result in any inhibition of platelet adhesion (IC50 greater than 500 microM). In contrast, VCL inhibited 50% of platelet adhesion at 0.94 microM and at 7.6 microM inhibited greater than 80% of platelet adhesion to human umbilical artery subendothelium at high shear forces. VCL inhibited the contact and spreading of platelets and also caused a marked decrease in thrombus formation. These studies indicate that VCL may be an effective antithrombotic agent in preventing arterial thrombus formation in areas of high shear force.
authors.affiliation: Hematology Service, National Institutes of Health, National Cancer Institute, Bethesda, MD 20892.
authors.forename: H R
authors.initials: HR
authors.lastname: Gralnick
authors.forename: S
authors.initials: S
authors.lastname: Williams
authors.forename: L
authors.initials: L
authors.lastname: McKeown
authors.forename: W
authors.initials: W
authors.lastname: Kramer
authors.forename: H
authors.initials: H
authors.lastname: Krutzsch
authors.forename: M
authors.initials: M
authors.lastname: Gorecki
authors.forename: A
authors.initials: A
authors.lastname: Pinet
authors.forename: L I
authors.initials: LI
authors.lastname: Garfinkel
mesh_terms: D000595:Amino Acid Sequence; D001667:Binding, Competitive; D006801:Humans; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism*; D011485:Protein Binding; D011994:Recombinant Proteins / Q000378:metabolism; D014841:von Willebrand Factor / Q000737:chemistry / Q000378:metabolism*
chemical_list: D010980:Platelet Membrane Glycoproteins; D011994:Recombinant Proteins; D014841:von Willebrand Factor